Podcast: Oregon abandons psilocybin fee hike as California funds research and DEA again moves to schedule five tryptamines

This episode of The Psychedelic News Feed covers major developments from a busy two-week period in psychedelic policy, research, regulation, and clinical science. Oregon’s Health Authority shelved a proposed doubling of fees charged to state-regulated psilocybin entities, with commentary from Taylor West of Healing Advocacy. California set aside $4.7 million for psychedelic research, while the DEA again moved toward scheduling five tryptamines. The episode also discusses a PATH Caucus request-for-information white paper and calls from Stanford and UCSF researchers for more aggressive blinding in psychedelic trials, including comments from UCSF’s Joshua Woolley. Together, the topics highlight evolving regulatory costs, public research funding, federal scheduling activity, policy advocacy, and methodological concerns affecting psychedelic studies.